101 related articles for article (PubMed ID: 11383178)
1. Issues surrounding adjuvant chemotherapy for breast cancer during pregnancy.
Peters BG; Bray JJ; Masidonski P; Mahon SM
Oncol Nurs Forum; 2001 May; 28(4):639-42. PubMed ID: 11383178
[No Abstract] [Full Text] [Related]
2. Adriamycin and cyclophosphamide chemotherapy in advanced breast cancer in pregnancy.
Skrablin S; Banović V; Matković V
Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):251-2. PubMed ID: 16860457
[No Abstract] [Full Text] [Related]
3. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.
Hahn KM; Johnson PH; Gordon N; Kuerer H; Middleton L; Ramirez M; Yang W; Perkins G; Hortobagyi GN; Theriault RL
Cancer; 2006 Sep; 107(6):1219-26. PubMed ID: 16894524
[TBL] [Abstract][Full Text] [Related]
4. [Breast carcinoma and pregnancy. A case report].
Serrano Migallón JA; Sandoval Guerrero F; Miranda Hernández H; de la Garza Navarro JM
Ginecol Obstet Mex; 1988 Oct; 56():281-4. PubMed ID: 2856450
[No Abstract] [Full Text] [Related]
5. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.
Ring AE; Smith IE; Jones A; Shannon C; Galani E; Ellis PA
J Clin Oncol; 2005 Jun; 23(18):4192-7. PubMed ID: 15961766
[TBL] [Abstract][Full Text] [Related]
6. A rare occurrence of primary T-cell lymphoma of the breast in pregnancy.
Ozkan K; Sehsuvar G; Erdem C; Mustafa C; Ibrahim S; Fatih O
Acta Oncol; 2011 Nov; 50(8):1262-3. PubMed ID: 21812625
[No Abstract] [Full Text] [Related]
7. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
Kerr JR
Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for breast cancer in pregnancy: can recommendations be made with confidence.
Stevenson J; Giantonio B; Boyd RL; Bruner JA
Semin Oncol; 1997 Apr; 24(2):xxv-xxxvi; discussion xxxvi, xxxix. PubMed ID: 9129684
[No Abstract] [Full Text] [Related]
9. Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraductal breast carcinoma.
Sharma JB; Pushparaj M; Kumar S; Roy KK; Raina V; Malhotra N
Arch Gynecol Obstet; 2009 Mar; 279(3):415-7. PubMed ID: 18642013
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for breast cancer during pregnancy.
Mathelin C; Annane K; Dufour P; Liegeois P; Bergerat JP
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):260-2. PubMed ID: 16024158
[No Abstract] [Full Text] [Related]
11. Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen.
Aksoy S; Harputluoglu H; Guler N; Altundag K; Hayran M; Tekuzman G; Ozisik Y
Breast J; 2007; 13(4):431-2. PubMed ID: 17593056
[No Abstract] [Full Text] [Related]
12. [Breast cancers associated with pregnancy. About two cases].
Ndioubnane MD; Mahmoud GO; Bal A
Tunis Med; 2005 Jun; 83(6):375-7. PubMed ID: 16156417
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care.
Epstein RJ
BMC Cancer; 2007 May; 7():92. PubMed ID: 17537241
[TBL] [Abstract][Full Text] [Related]
14. [Toxicity of doxorubicin and cyclophosphamide (60 mg/600 mg/m2) in adjuvant chemotherapy for breast cancer].
Tsutani Y; Saeki T; Aogi K; Ohsumi S; Takashima S
Gan To Kagaku Ryoho; 2005 Jun; 32(6):809-13. PubMed ID: 15984521
[TBL] [Abstract][Full Text] [Related]
15. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
Andreadis C; Charalampidou M; Diamantopoulos N; Chouchos N; Mouratidou D
Gynecol Oncol; 2004 Oct; 95(1):252-5. PubMed ID: 15385141
[TBL] [Abstract][Full Text] [Related]
16. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
17. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
Tamura K
Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
[No Abstract] [Full Text] [Related]
18. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature.
Gadducci A; Cosio S; Fanucchi A; Nardini V; Roncella M; Conte PF; Genazzani AR
Anticancer Res; 2003; 23(6D):5225-9. PubMed ID: 14981994
[TBL] [Abstract][Full Text] [Related]
19. Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).
Linden HM; Haskell CM; Green SJ; Osborne CK; Sledge GW; Shapiro CL; Ingle JN; Lew D; Hutchins LF; Livingston RB; Martino S
J Clin Oncol; 2007 Feb; 25(6):656-61. PubMed ID: 17308269
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy and parenthood after treatment for breast cancer.
Hassey KM
Oncol Nurs Forum; 1988; 15(4):439-44. PubMed ID: 3041382
[No Abstract] [Full Text] [Related]
[Next] [New Search]